Last reviewed · How we verify

NCT06114602

Impact of Email Reminders on No-Show Rates for Appointments in an Urology Department

Status unknown Last updated 7 November 2023
What this trial tests

trial testing E-Mail Reminder in No-Show Patients in 1,892 participants. Status unknown.

Timeline
1 January 2022
Primary endpoint
31 December 2023
30 March 2024

Quick facts

Lead sponsorHospital Italiano de Buenos Aires
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,892
Start date1 January 2022
Primary completion31 December 2023
Estimated completion30 March 2024
Sites1 location across Argentina

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Italiano de Buenos Aires

Who can join

18 and older, any sex, with No-Show Patients or Reminder Systems. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this observational study, the investigators will analyze all patients who have scheduled appointments in the Urology Department from twelve months before the start date of the e-mail reminder dispatch (01/02/2023) to twelve months after (01/01/2022 to 31/12/2023). The investigators will divide them into two groups based on whether they have received the reminder or not. The investigators are going to compare the rate of no-show rates in both groups and then obtain the relative risk of the association between appointment reminders and no-show rates.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hospital Italiano de Buenos Aires trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06114602.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing